A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

NCT07738822 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Thrombocytopenia (ITP)
Warm Autoimmune Hemolytic Anemia (WAIHA)

Interventions

DRUG: Velinotamig specified dose on specified days.

Sponsor

Cullinan Therapeutics Inc.